Oxfam: Any malaria vaccine must be affordable for poor

A new potential vaccine for malaria will only have an impact if it is made affordable to people in poor countries, Oxfam's health policy adviser Anna Marriott has warned.

Kenyan nurses weigh a child before she is given an injection as part of a malaria vaccine trial in Kenya Credit: REUTERS/Joseph Okanga

She said previous cases show that companies can make drugs affordable to African governments, which can then provide treatments free of charge to poor people.

Marriott also stressed that the impact would be limited unless deployed alongside other tools, such as mosquito nets, better diagnosis and healthcare infrastructure.

"We cannot let excitement [about a possible vaccine] ... divert attention away from the need to invest in these prevention and treatment methods," she added.